Calan



Indications and Reactions:

Role Indications Reactions
Primary
Hypertension 34.0%
Product Used For Unknown Indication 32.1%
Ill-defined Disorder 7.8%
Migraine 3.5%
Blood Cholesterol Increased 2.4%
Blood Pressure Abnormal 2.4%
Diabetes Mellitus 2.2%
Palpitations 2.2%
Asthma 1.7%
Blood Pressure 1.5%
Gastrooesophageal Reflux Disease 1.3%
Cardiac Disorder 1.1%
Hypothyroidism 1.1%
Mitral Valve Prolapse 1.1%
Supraventricular Tachycardia 1.1%
Arrhythmia 0.9%
Bone Disorder 0.9%
Tachyarrhythmia 0.9%
Thyroid Disorder 0.9%
Atrial Fibrillation 0.7%
Completed Suicide 23.7%
Somnolence 8.6%
Myocardial Infarction 7.2%
Death 6.6%
Drug Ineffective 5.9%
Medication Error 5.9%
Weight Increased 5.3%
Dyspnoea 3.9%
Intentional Overdose 3.9%
Constipation 3.3%
Drug Dispensing Error 3.3%
Loss Of Consciousness 3.3%
Rash 3.3%
Arthralgia 2.6%
Blood Cholesterol Increased 2.6%
Weight Decreased 2.6%
Dizziness 2.0%
Fatigue 2.0%
Headache 2.0%
Heart Rate Decreased 2.0%
Secondary
Hypertension 28.4%
Product Used For Unknown Indication 16.4%
Migraine 10.8%
Atrial Fibrillation 4.7%
Palpitations 4.7%
Blood Cholesterol Increased 4.1%
Depression 4.1%
Anxiety 3.5%
Thyroid Disorder 2.6%
Cardiac Valve Disease 2.3%
Asthma 2.0%
Hypothyroidism 2.0%
Mitral Valve Prolapse 2.0%
Breast Cancer 1.8%
Bundle Branch Block Right 1.8%
Diabetes Mellitus 1.8%
Headache 1.8%
Heart Rate Irregular 1.8%
Hyperthyroidism 1.8%
Hypertonic Bladder 1.8%
Somnolence 9.4%
Malaise 8.2%
Weight Increased 8.2%
Crohn's Disease 5.9%
Headache 5.9%
Hypertension 5.9%
Weight Decreased 5.9%
Dizziness 4.7%
Drug Hypersensitivity 4.7%
Migraine 4.7%
Vasoconstriction 4.7%
Drug Ineffective 3.5%
Hypotension 3.5%
Loss Of Consciousness 3.5%
Medication Error 3.5%
Off Label Use 3.5%
Ovarian Cancer 3.5%
Rash 3.5%
Spinal Disorder 3.5%
Ventricular Extrasystoles 3.5%
Concomitant
Hypertension 13.9%
Product Used For Unknown Indication 12.9%
Drug Use For Unknown Indication 11.9%
Prophylaxis 9.5%
Hormone Replacement Therapy 5.8%
Pain 5.4%
Chronic Obstructive Pulmonary Disease 4.8%
Rheumatoid Arthritis 3.8%
Atrial Fibrillation 3.8%
Migraine 3.8%
Depression 3.5%
Anticoagulant Therapy 3.0%
Metastatic Renal Cell Carcinoma 3.0%
Arthritis 2.7%
Gastrooesophageal Reflux Disease 2.4%
Cardiac Disorder 2.2%
Diabetes Mellitus 2.2%
Hyperlipidaemia 2.1%
Angina Pectoris 1.7%
Osteoporosis 1.7%
Vomiting 16.2%
Myocardial Infarction 13.0%
Tremor 7.0%
Breast Cancer Female 4.9%
Pneumonia 4.9%
Urinary Tract Infection 4.9%
Weight Increased 4.9%
Pain In Extremity 4.3%
Wheezing 4.3%
Drug Ineffective 3.8%
Pain 3.8%
Nausea 3.2%
Pharmaceutical Product Complaint 3.2%
Renal Failure Acute 3.2%
Transient Ischaemic Attack 3.2%
Type 2 Diabetes Mellitus 3.2%
Weight Decreased 3.2%
White Blood Cell Count Increased 3.2%
Headache 2.7%
Myalgia 2.7%
Interacting
Hypertension 100.0%
Electrocardiogram Qt Prolonged 100.0%